Choline and n-acetylaspartate were present at lower levels in the brains of patients with anxiety disorders, according to a ...

A&Z currently uses its buildings for domestic sales and as a laboratory, research and development, and manufacturing site for the export of over-the-counter pharmaceuticals, nutraceuticals and ...

Cases that could have been settled quickly for a fraction of the ultimate cost have instead become years-long courtroom ...

New research published in the Journal of Personality provides evidence that fundamental assumptions about the nature of the ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...

Deaf Refugees, Mental Health, Trauma Informed Care, Intersectionality, Cultural Competence, Refugee Resettlement Share and ...

Humans navigate today's world with a genetic profile largely the same as that of our Paleolithic ancestors, which has ...

What if your endless questions about life, death, and reality aren’t a sign you’re “losing it,” but a specific, treatable ...

This study presents a valuable tool named TSvelo, a computational framework for RNA velocity inference that models transcriptional regulation and gene-specific splicing. The evidence supporting the ...

Introduction Depressed mood is a psychological state characterised by sadness or loss of interest in activities, is a common symptom that accompanies most major mental disorders. It is therefore ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...